NO20005547L - Myelin base protein peptides and uses thereof - Google Patents

Myelin base protein peptides and uses thereof

Info

Publication number
NO20005547L
NO20005547L NO20005547A NO20005547A NO20005547L NO 20005547 L NO20005547 L NO 20005547L NO 20005547 A NO20005547 A NO 20005547A NO 20005547 A NO20005547 A NO 20005547A NO 20005547 L NO20005547 L NO 20005547L
Authority
NO
Norway
Prior art keywords
protein peptides
base protein
myelin base
myelin
peptides
Prior art date
Application number
NO20005547A
Other languages
Norwegian (no)
Other versions
NO20005547D0 (en
Inventor
Subhashini Arimilli
Shrikant Deshpande
Original Assignee
Corixa Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Corixa Corp filed Critical Corixa Corp
Publication of NO20005547D0 publication Critical patent/NO20005547D0/en
Publication of NO20005547L publication Critical patent/NO20005547L/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4713—Autoimmune diseases, e.g. Insulin-dependent diabetes mellitus, multiple sclerosis, rheumathoid arthritis, systemic lupus erythematosus; Autoantigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurology (AREA)
  • Rehabilitation Therapy (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Hospice & Palliative Care (AREA)
  • Rheumatology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Psychiatry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
NO20005547A 1998-05-05 2000-11-03 Myelin base protein peptides and uses thereof NO20005547L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US7310998A 1998-05-05 1998-05-05
PCT/US1999/009930 WO1999057241A2 (en) 1998-05-05 1999-05-05 Myelin basic protein peptides and uses thereof

Publications (2)

Publication Number Publication Date
NO20005547D0 NO20005547D0 (en) 2000-11-03
NO20005547L true NO20005547L (en) 2001-01-02

Family

ID=22111789

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20005547A NO20005547L (en) 1998-05-05 2000-11-03 Myelin base protein peptides and uses thereof

Country Status (10)

Country Link
EP (1) EP1080185A4 (en)
JP (1) JP2002513558A (en)
CN (1) CN1308671A (en)
AU (1) AU3789099A (en)
CA (1) CA2330826A1 (en)
HK (1) HK1039636A1 (en)
NO (1) NO20005547L (en)
NZ (1) NZ507901A (en)
WO (1) WO1999057241A2 (en)
ZA (1) ZA200006268B (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA03010037A (en) * 2001-05-01 2004-06-30 Univ California Fusion molecules and methods for treatment of immune diseases.
US7265208B2 (en) 2001-05-01 2007-09-04 The Regents Of The University Of California Fusion molecules and treatment of IgE-mediated allergic diseases
ITFI20010114A1 (en) * 2001-06-22 2002-12-22 Univ Firenze GLYCOPEPTIDES, THEIR PREPARATION AND THEIR USE IN THE DIAGNOSIS OR THERAPEUTIC TREATMENT OF MULTIPLE SCLEROSIS
PL2227486T3 (en) * 2007-11-20 2017-09-29 Vianex S.A. Peptide analogues and conjugates thereof
AU2016241035B2 (en) * 2015-03-30 2018-10-04 Osaka University Immunizing peptide, method for producing immunizing peptide, pharmaceutical composition for immune disease containing same, and method for treating immune disease
JP7818405B2 (en) * 2019-06-18 2026-02-20 ザ スクリプス リサーチ インスティテュート Methods and compositions for treating inflammatory conditions

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5734023A (en) * 1991-11-19 1998-03-31 Anergen Inc. MHC class II β chain/peptide complexes useful in ameliorating deleterious immune responses
IL115766A0 (en) * 1994-10-25 1996-01-19 Immulogic Pharma Corp Composition and treatment for multiple sclerosis
CA2224205A1 (en) * 1995-06-07 1996-12-19 Zymogenetics, Inc. Fused soluble mhc heterodimer-peptide complexes and their uses

Also Published As

Publication number Publication date
WO1999057241A9 (en) 2000-02-17
WO1999057241A2 (en) 1999-11-11
CN1308671A (en) 2001-08-15
EP1080185A2 (en) 2001-03-07
ZA200006268B (en) 2001-08-22
WO1999057241A3 (en) 2000-01-13
EP1080185A4 (en) 2005-01-26
CA2330826A1 (en) 1999-11-11
HK1039636A1 (en) 2002-05-03
JP2002513558A (en) 2002-05-14
NO20005547D0 (en) 2000-11-03
AU3789099A (en) 1999-11-23
NZ507901A (en) 2003-06-30

Similar Documents

Publication Publication Date Title
ITMI982280A0 (en) SOME N-(2-APRIL-PROPIONIL)-SULFONAMIDES AND PHARMACEUTICAL PREPARATIONS WHICH CONTAIN THEM
NO20000700D0 (en) Interleukin-18 proteins and their preparation and use
NO20040246L (en) TACIs and BR3 polypeptides and uses thereof
EP1461605A4 (en) Protein and peptide nanoarrays
NO982097D0 (en) peptides
NO982098D0 (en) peptides
NO991150D0 (en) Pyrazolopyrimidines and pyrazolotriazines
IS1810B (en) Peptide and protein aerosols
NO20034962D0 (en) Beta-amyloid peptide-binding proteins and polynucleotides encoding the same
DE69822917D1 (en) Sample and hold circuit
EP1056465A4 (en) ANTIMICROBIAL PEPTIDES AND DERIVED METAPEPTIDES
NO20040880L (en) Casein-derived peptides and applications thereof in therapy.
DE69705017D1 (en) Drug binding protein
NO20005547L (en) Myelin base protein peptides and uses thereof
NO995062D0 (en) <Beta> -anyloid peptide binding proteins and polynuldeotides encoded for the same
GB9918155D0 (en) Proteins and peptides
DE69816241D1 (en) ACTIVATED PEPTIDES AND CONJUGATES
ATA1972000A (en) RECOMBINANTLY MADE INTESTINAL NPT2B POLYPEPTIDE
TR199701666A3 (en) Proteins
IL153740A0 (en) Grf2-binding proteins and applications thereof
NO20020794D0 (en) Me-1 protein
EP1151100A4 (en) PEPTIDES DESIGNED TAU-CONOTOXINS
GB0102447D0 (en) Protein variants and uses thereof
DK0907370T3 (en) HLA-A2.1 Binding Peptides and Their Uses
ID26084A (en) AMINO ANTRASICLINON HERITIES

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application